Home / Street Sector / Stocks Highjack By Analysts Estimates: Applied Materials, Inc. (NASDAQ:AMAT), Teradyne Inc. (NYSE:TER)

Stocks Highjack By Analysts Estimates: Applied Materials, Inc. (NASDAQ:AMAT), Teradyne Inc. (NYSE:TER)

Applied Materials, Inc. (NASDAQ:AMAT) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -2.08% to close at $29.66 with the total traded volume of 13.97 Million shares. Barclays started coverage of the stock with an “equal weight” rating and $33 price target.  The firm called the Cincinnati-based food and drug store operator one of its “stable staples,” or companies that are gaining positive traffic and have “appropriate” long term strategies.

Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked AMAT in recent few months. In ratings table the AMAT given BUY ratings by 21 analysts in current phase. The no one analyst has SELL recommendation for current month on AMAT. While 4 number of analysts gave ratings for HOLD in current. As per remarks given by WSJ, overall consensus pool recommend it as Buy security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $0.65 at current month while compared with $0.65 in a month ago. The stock next year first quarter current estimate trend for EPS was for $0.58 and on annual basis FY 2016 estimate trends at current was for $1.75 as compared to one month ago of $1.75, and for next year per share earnings estimates have $2.26.

The firm has institutional ownership of 84.90%, while insider ownership included 0.30%. Its price to sales ratio ended at 3.25. AMAT attains analyst recommendation of 1.90 with week performance of -1.30%.

Teradyne Inc. (NYSE:TER) [Trend Analysis] plunged reacts as active mover, shares a decrease -1.25% to traded at $21.29 and the percentage gap between open changing to regular change was -0.42%. The TER held a rough session during the week but was ready to get some critical analysis. The stock was assessed by a pool of analysts at WSJ and came out with some serious outcomes not to be avoided before making investment. The TER ratings chart showed that 7 gave HOLD ratings for the current month as 0 analysts opting for Overweight option for same period, whereas, 1 analyst out of pool gave UNDERWEIGHT rating. For stocks’ current month, 7 analysts opted for BUY ratings as compared to 0 opting for SELL in the same period. The stock price target chart showed average price target of 22.37 as compared to current price of 21.29.

Taking look on per share earnings estimates, its next year first quarter current estimate trend for EPS was for $0.12 and on annual basis FY 2016 estimate trends at current was for $1.26 as compared to one month ago of $1.26, and for next year per share earnings estimates have $1.42.

The firm’s current ratio calculated as 3.10 for the most recent quarter. The firm past twelve months price to sales ratio was 2.47 and price to cash ratio remained 5.24. As far as the returns are concern, the return on equity was recorded as -5.30% and return on investment was 10.00% while its return on asset stayed at -4.00%.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Tesla Motors Inc (TSLA)

Tesla Motors Inc (TSLA) Hints Upgrade to Nevada Gigafactory with Electric Motors

There is something exciting about Tesla Motors (TSLA) “Nevada Gigafactory”; The production department has decided …

Leave a Reply

Your email address will not be published. Required fields are marked *